Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Seminars in Oncology

• Publication date

  1990-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5555/URI:PII:009377549090003LPMID 2259930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical study of hydrazine sulfate in advanced cancer patients

  2004cited by this paper
• A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

  1990cited by this paper
• Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.

  1990cited by this paper
• A Prospective, Randomized Controlled Trial of Megestrol Acetate Among High‐Risk Patients with Resected Malignant Melanoma

  1989cited by this paper
• Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.

  1988cited by this paper
• Hydrazine sulfate in cancer patients with weight loss. A placebo‐controlled clinical experience

  1987cited by this paper
• Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patients.

  1987cited by this paper
• The value of parenteral nutrition support: Chemotherapy and radiation treatment

  1986cited by this paper
• Total parenteral nutrition and cancer clinical trials

  1986cited by this paper
• Megestrol acetate in the treatment of advanced post-menopausal breast cancer.

  1986cited by this paper
• Appetite stimulation with megestrol acetate in cachectic cancer patients.

  1986cited by this paper
• High-dose pilot studies in extensive-stage small-cell lung cancer.

  1986cited by this paper
• Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.

  1985cited by this paper
• Megestrol acetate therapy for advanced breast cancer.

  1985cited by this paper
• Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.

  1985cited by this paper
• Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.

  1985cited by this paper
• Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.

  1984cited by this paper
• Cyproheptadine, an antidepressant and weight-inducing drug for anorexia nervosa

  1983cited by this paper
• Correlation of changes in brain indoleamine metabolism with onset of anorexia in rats.

  1982cited by this paper
• Cyproheptadine for anorexia nervosa.

  1982cited by this paper
• Results of clinical study antitumor action of hydrazine sulfate.

  1981cited by this paper
• Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

  1980cited by this paper
• Prognostic factors for survival in patients with inoperable lung cancer.

  1980cited by this paper
• Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings].

  1980cited by this paper
• Cyproheptadine in Anorexia Nervosa

  1979cited by this paper
• Brain tryptophan and the neoplastic anorexia‐cachexia syndrome

  1979cited by this paper
• Cyproheptadine in anorexia nervosa [proceedings].

  1978cited by this paper
• Effects of the diet on brain neurotransmitters

  1977cited by this paper
• Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine.

  1976cited by this paper
• Clinical trial of hydrazine sulfate in solid tumors.

  1976cited by this paper
• Cyproheptadine: weight-gain and appetite stimulation in essential anorexic adults.

  1975cited by this paper
• Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients.

  1975cited by this paper
• Trial of hydrazine sulfate (NSC-150014) in patients with cancer.

  1975cited by this paper
• Corticosteroid therapy of preterminal gastrointestinal cancer

  1974cited by this paper
• Effect of cyproheptadine on anorexia and loss of weight in adults.

  1972cited by this paper
• Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet

  1971cited by this paper
• Weight gain with cyproheptadine hydrochloride ('Periactin'). A double blind trial in underweight medical students.

  1970cited by this paper
• Appetite stimulation and weight gain with cyproheptadine. A double-blind study in underweight children.

  1970cited by this paper
• Inhibition by hydrazine of gluconeogenesis in the rat.

  1970cited by this paper
• Effect of cyproheptadine on appetite and weight gain in adults.

  1969cited by this paper
• THE IMMEDIATE CAUSES OF DEATH IN CANCER

  1932cited by this paper

• Megestrol Acetate in the Treatment of Post COVID-19 Fatigue in a Patient of Advanced Cancer: A Case Report and Mini Review of Literature

  2022cites this paper
• Anorexia

  2020cites this paper
• Review Article Management of Malnutrition in Esophageal Cancer Patients

  2014cites this paper
• Management of Malnutrition in Esophageal Cancer Patients

  2014cites this paper
• Clinical evaluation and optimal management of cancer cachexia.

  2013cites this paper
• Megestrol acetate for treatment of anorexia-cachexia syndrome.

  2013cites this paper
• Cachexia-anorexia cancer-related syndrome – megestrol acetate as a treatment option

  2012cites this paper
• IL-6/IL-6 receptor system and its role in physiological and pathological conditions.

  2012cites this paper
• Meta‐analysis: Perioperative regional liver chemotherapy for improving survival and preventing liver metastases in patients with colorectal carcinoma

  2010cites this paper
• CHAPTER 2 – Nutritional Management in Head and Neck Cancer

  2009cites this paper
• Estudio de fase II randomizado de dos niveles posológicos de acetato de megestrol versus placebo para el tratamiento de la anorexia y la caquexia en pacientes con cáncer locoregional avanzado o metastásico

  2008influential citation
• Megestrol acetate for the treatment of anorexia-cachexia syndrome.

  2005cites this paper
• Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome.

  2004cites this paper
• Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

  2003cites this paper
• Corticosteroids in advanced cancer.

  2001cites this paper
• Corticosteroids in advanced cancer.

  2001cites this paper
• Effects of megestrol acetate and testosterone on body composition in castrated male Sprague-Dawley rats.

  1999cites this paper
• Pharmacologic Options for the Treatment of Cachexia

  1997cites this paper
• Low dose megestrol increases serum albumin in malnourished dialysis patients.

  1996cites this paper
• Bodyweight Change as an Adverse Effect of Drug Treatment

  1996cites this paper
• Low dose megestrol increases serum albumin in malnourished dialysis patients.

  1996cites this paper
• Insulin-like Growth Factor-I et dénutrition aiguë ou chronique

  1996cites this paper
• Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patients

  1994cites this paper
• The HIV wasting syndrome: a review.

  1994cites this paper
• Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone.

  1994cites this paper
• Appetite stimulants in terminal care: treatment of anorexia.

  1993cites this paper
• Is the pharmacological treatment of cancer cachexia possible?

  1993cites this paper
• Clinical management of anorexia and cachexia in patients with advanced cancer.

  1992cites this paper